Stock listing
OTC:AVTH AV Therapeutics Stock
Follow AV Therapeutics into a list and get an email when it puts out news.
Delisted OTC:AVTH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- OTC:AVTH
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
AV Therapeutics on 6ix
- Decks
- 2 decks · latest Jun 25, 2015
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (June 2015) | Investor deck | 15 slides | Jun 25, 2015 |
| Investor Presentation (January 2015) | Investor deck | 19 slides | Jan 16, 2015 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Morton Coleman Other companies: Immunomedics Inc (Director · Aug 24, 2006 – Dec 4, 2013 · Past) | Vice President · Feb 21, 2014 – Feb 21, 2014 · Past |
| Abraham Mittelman | CEO and CFO, Director · Feb 21, 2014 – Jan 20, 2015 · Past |
| Debabrata Banerjee | Clinical Development Officer · Feb 21, 2014 – Feb 21, 2014 · Past |
| Raj Kumar Tiwari | Chief Scientific Officer, Director · Feb 21, 2014 – Feb 21, 2014 · Past |
| Robert S Pollock | Pres & Chief Operating Officer · Feb 21, 2014 – Feb 21, 2014 · Past |
Log in to ask 6ix AI your own questions about AV Therapeutics.